Omega Diagnostics Group PLC reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was GBP 3.43 million compared to GBP 4.17 million a year ago. Net loss was GBP 2.09 million compared to GBP 2.75 million a year ago.

Basic loss per share from continuing operations was GBP 0.003 compared to basic earnings per share from continuing operations of GBP 0.004 a year ago. Diluted loss per share from continuing operations was GBP 0.003 compared to diluted earnings per share from continuing operations of GBP 0.004 a year ago. Basic loss per share was GBP 0.009 compared to GBP 0.015 a year ago.

Diluted loss per share was GBP 0.009 compared to GBP 0.015 a year ago.